Integral Diagnostics Crecimiento futuro
Future controles de criterios 4/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Integral Diagnostics de 92.2% y 9.9% por año respectivamente. Se prevé que el BPA crezca en un 97.2% al año. Se espera que la rentabilidad financiera sea de 12.7% en 3 años.
Información clave
92.2%
Tasa de crecimiento de los beneficios
97.2%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Healthcare | 26.3% |
| Tasa de crecimiento de los ingresos | 9.9% |
| Rentabilidad financiera futura | 12.7% |
| Cobertura de analistas | Good |
| Última actualización | 01 Nov 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital
Feb 21
Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being
Nov 22Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year
Feb 20These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively
Dec 14Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?
May 26Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year
Feb 28Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate
Feb 25Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why
Oct 29Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?
Sep 13An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued
Jun 04Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?
May 14Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?
May 03We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt
Apr 16Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?
Mar 27Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?
Mar 17The Trends At Integral Diagnostics (ASX:IDX) That You Should Know About
Mar 07Here's What We Like About Integral Diagnostics' (ASX:IDX) Upcoming Dividend
Feb 25Is Integral Diagnostics Limited (ASX:IDX) Popular Amongst Institutions?
Feb 23Have Insiders Been Selling Integral Diagnostics Limited (ASX:IDX) Shares?
Feb 13Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price
Feb 03
Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)
Jan 24Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?
Jan 14Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return
Jan 05Is Integral Diagnostics (ASX:IDX) A Risky Investment?
Dec 26At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?
Dec 17What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend
Dec 08Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture
Nov 29Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?
Nov 19Is Integral Diagnostics (ASX:IDX) A Risky Investment?
Sep 20Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 6/30/2027 | 646 | 43 | 94 | 116 | 4 |
| 6/30/2026 | 566 | 30 | 63 | 87 | 8 |
| 6/30/2025 | 526 | 23 | 52 | 79 | 7 |
| 6/30/2024 | 470 | -61 | 42 | 66 | N/A |
| 3/31/2024 | 463 | -59 | 29 | 62 | N/A |
| 12/31/2023 | 456 | -58 | 20 | 62 | N/A |
| 9/30/2023 | 449 | -16 | 24 | 67 | N/A |
| 6/30/2023 | 441 | 25 | 23 | 67 | N/A |
| 3/31/2023 | 418 | 23 | 20 | 56 | N/A |
| 12/31/2022 | 395 | 21 | 17 | 45 | N/A |
| 9/30/2022 | 378 | 18 | 13 | 41 | N/A |
| 6/30/2022 | 361 | 15 | 9 | 37 | N/A |
| 3/31/2022 | 361 | 18 | 14 | 41 | N/A |
| 12/31/2021 | 360 | 22 | 18 | 44 | N/A |
| 9/30/2021 | 356 | 26 | 34 | 57 | N/A |
| 6/30/2021 | 351 | 31 | 49 | 70 | N/A |
| 3/31/2021 | 333 | 32 | 54 | 73 | N/A |
| 12/31/2020 | 315 | 32 | 59 | 76 | N/A |
| 9/30/2020 | 295 | 28 | 44 | 65 | N/A |
| 6/30/2020 | 276 | 23 | 28 | 54 | N/A |
| 3/31/2020 | 263 | 22 | 19 | 47 | N/A |
| 12/31/2019 | 250 | 21 | 9 | 39 | N/A |
| 9/30/2019 | 241 | 21 | 12 | 37 | N/A |
| 6/30/2019 | 232 | 21 | 15 | 34 | N/A |
| 3/31/2019 | 222 | 19 | 14 | 30 | N/A |
| 12/31/2018 | 211 | 17 | 13 | 26 | N/A |
| 9/30/2018 | 200 | 16 | 14 | 26 | N/A |
| 6/30/2018 | 189 | 15 | 15 | 27 | N/A |
| 3/31/2018 | 187 | 15 | N/A | 27 | N/A |
| 12/31/2017 | 185 | 15 | N/A | 27 | N/A |
| 9/30/2017 | 182 | 15 | N/A | 25 | N/A |
| 6/30/2017 | 180 | 15 | N/A | 23 | N/A |
| 3/31/2017 | 177 | 16 | N/A | 26 | N/A |
| 12/31/2016 | 175 | 16 | N/A | 30 | N/A |
| 9/30/2016 | 171 | 14 | N/A | 27 | N/A |
| 6/30/2016 | 168 | 11 | N/A | 24 | N/A |
| 3/31/2016 | 165 | 11 | N/A | 22 | N/A |
| 12/31/2015 | 162 | 11 | N/A | 20 | N/A |
| 9/30/2015 | 157 | 8 | N/A | 18 | N/A |
| 6/30/2015 | 151 | 5 | N/A | 17 | N/A |
| 6/30/2014 | 4 | 3 | N/A | 4 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Se prevé que IDX sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (2.4%).
Beneficios vs. Mercado: Se prevé que IDX sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.
Beneficios de alto crecimiento: Se espera que IDX sea rentable en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (9.9% al año) de IDX crezcan más rápidamente que los del mercado Australian (5.6% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 9.9% al año) de IDX crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de IDX sea baja dentro de 3 años (12.7%).